Cellosaurus T101 [Mouse hybridoma against human CD5] (CVCL_DC79)
| Cell line name | T101 [Mouse hybridoma against human CD5] |
|---|---|
| Accession | CVCL_DC79 |
| Resource Identification Initiative | To cite this cell line use: T101 [Mouse hybridoma against human CD5] (RRID:CVCL_DC79) |
| Comments | Group: Patented cell line. Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8023. Monoclonal antibody isotype: IgG2a. Monoclonal antibody target: UniProtKB; P06127; Human CD5. Anecdotal: The T101 mAb was one of the earliest mAbs to be tested in clinical trials against cutaneous T cell lymphoma (CTCL) and chronic lymphocytic leukemia (CLL). |
| Species of origin | Mus musculus (Mouse) (NCBI Taxonomy: 10090) |
| Hierarchy | Parent: CVCL_2155 (P3/NS1/1-Ag4.1) |
| Category | Hybridoma |
| Publications | CLPUB00335 PubMed=6993560; DOI=10.4049/jimmunol.125.2.725 Patent=US4675386 |
| Cross-references | |
| Encyclopedic resources | Wikidata; Q54971407 |
| Entry history | |
| Entry creation | 13-Jul-2016 |
| Last entry update | 21-Mar-2023 |
| Version number | 6 |